Abstract
Objective Dysregulated appetite control is characteristic of anorexia nervosa (AN), bulimia nervosa (BN) and obesity (OB). Studies using a broad range of methods suggest the cerebellum plays an important role in aspects of weight and appetite control, and is implicated in both AN and OB by reports of aberrant grey matter volume (GMV) compared to non-clinical populations. As functions of the cerebellum are anatomically segregated, specific localization of aberrant anatomy may indicate the mechanisms of its relationship with weight and appetite in different states. We sought to determine if there were consistencies in regions of cerebellar GMV changes in AN/BN and OB, as well as across normative variation.
Method Systematic review and meta-analysis using GingerALE.
Results Twenty-six publications were identified as either case-control studies (nOB=277; nAN/BN=510) or regressed weight from normative (NOR) data against brain volume (total n=3,830). AN/BN and OB analyses both showed consistently decreased GMV within Crus I and Lobule VI, but volume reduction was bilateral for AN/BN and unilateral for OB. Analysis of the normative dataset identified a cluster in right posterior lobe which overlapped with AN/BN cerebellar reduction. Sensitivity analyses indicated robust repeatability for NOR and AN/BN cohorts, but found OB-specific heterogeneity.
Discussion Findings suggest that more than one area of the cerebellum is involved in control of eating behaviour and is differentially affected in normal variation and pathological conditions. Specifically, we hypothesise an association with sensorimotor and emotional learning via Lobule VI in AN/BN, and executive function via Crus I in OB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The studentship propelling this study has been funded by an external grant supplied by the Northwood Charitable Trust (RG15207 & RG13425).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Source MRI and demographic participant data was supplied from previously published studies on open-access platforms (i.e. PUBMED (https://pubmed.ncbi.nlm.nih.gov/), SCOPUS (https://www.elsevier.com/en-gb/solutions/scopus), Web of Science (https://www.webofscience.com/wos/woscc))
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This revision provides respective evaluations of AN-only literature vs. AN + BN literature. Cohort-specific sensitivity jackknife analyses were also conducted in this revision to assess heterogeneity of findings.
Data Availability
Data produced in this study are available upon reasonable request to the corresponding author.
